HEALTHDAILY MAIL
Superdrug launch STI 'morning after pill' that prevents chlamydia - as cases surge across UK
Superdrug has launched an STI 'morning after pill' designed to prevent chlamydia as cases of the infection rise across the UK.
Related Signal
Adjacent reporting
- London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
- At last, a pill that can prevent COVID after exposure to infected people
- Wegovy pills go on sale at Superdrug for £79 - as high street pharmacy becomes the first to launch weight-loss tablets
- How an HKU-developed eczema product could help fight superbug threat
- Hundreds of thousands of women get morning-after pill via free pharmacy service
- Warning over surge in 'virtually untreatable' sexually transmitted diarrhoea disease that's climbing in the UK